<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
71161-106-01
</NDCCode>
<PackageDescription>
2 mL in 1 VIAL (71161-106-01)
</PackageDescription>
<NDC11Code>
71161-0106-01
</NDC11Code>
<ProductNDC>
71161-106
</ProductNDC>
<ProductTypeName>
DRUG FOR FURTHER PROCESSING
</ProductTypeName>
<ProprietaryName/>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Triptorelin
</NonProprietaryName>
<DosageFormName>
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
</DosageFormName>
<RouteName/>
<StartMarketingDate>
20170908
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
DRUG FOR FURTHER PROCESSING
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Synergy Health AST, Inc
</LabelerName>
<SubstanceName>
TRIPTORELIN
</SubstanceName>
<StrengthNumber>
22.5
</StrengthNumber>
<StrengthUnit>
mg/2mL
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Unfinished
</Status>
<LastUpdate>
2023-06-27
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough>
20241231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
08-SEP-17
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>